Literature DB >> 3816940

Dopamine antagonists induce gastric lesions in rats.

P Sikirić, J Geber, D Ivanović, E Suchanek, V Gjuris, M Tućan-Foretić, S Mise, B Cvitanović, I Rotkvić.   

Abstract

Gastric lesions were provoked in all rats that had received intraperitoneally a single dose of the dopamine antagonists haloperidol, metoclopramide or domperidone 24 h before. Dose-dependence was demonstrated for haloperidol. This drug induced gastric lesions as early as 90 min after its application. The ulcerogenic effect of haloperidol was completely prevented or markedly reduced by simultaneous applications of dopamine agonists bromocriptine or L-dopa. We conclude that the model of gastric lesions induced by dopamine antagonists could be successfully applied in further investigations of the role of dopamine in the pathogenesis of ulcer disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3816940     DOI: 10.1016/0014-2999(86)90522-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine.

Authors:  P Sikiric; I Rotkvic; S Mise; M Petek; R Rucman; S Seiwerth; V Zjacic-Rotkvic; M Duvnjak; V Jagic; E Suchanek
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

Review 2.  The amygdala. Emotions and gut functions.

Authors:  P G Henke; A Ray; R M Sullivan
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

3.  Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats.

Authors:  P Sikirić; S Seiwerth; Z Grabarević; R Rucman; M Petek; V Jagić; B Turković; I Rotkvić; S Mise; I Zoricić; L Jurina; P Konjevoda; M Hanzevacki; D Ljubanović; J Separović; M Gjurasin; M Bratulić; B Artuković; N Jelovac; G Buljat
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

4.  Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress.

Authors:  P Sikirić; B Mazul; S Seiwerth; Z Grabarević; R Rucman; M Petek; V Jagić; B Turković; I Rotkvić; S Mise; I Zoricić; L Jurina; P Konjevoda; M Hanzevacki; M Gjurasin; J Separović; D Ljubanović; B Artuković; M Bratulić; M Tisljar; P Miklić; J Sumajstorcić
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

5.  Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicity.

Authors:  P Sikirić; S Seiwerth; Z Grabarević; R Rucman; M Petek; V Jagić; B Turković; I Rotkvić; S Mise; I Zoricić; M Gjurasin; P Konjevoda; J Separović; D Ljubanović; B Artuković; M Bratulić; M Tisljar; L Jurina; G Buljat; P Miklić; A Marović
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

6.  Gastric and duodenal anti-ulcer activity of sulpiride, a dopamine D2 receptor antagonist, in rats.

Authors:  J K Desai; N S Parmar
Journal:  Agents Actions       Date:  1994-10

7.  Class side effects: decreased pressure in the lower oesophageal and the pyloric sphincters after the administration of dopamine antagonists, neuroleptics, anti-emetics, L-NAME, pentadecapeptide BPC 157 and L-arginine.

Authors:  Zeljka Belosic Halle; Josipa Vlainic; Domagoj Drmic; Dean Strinic; Kresimir Luetic; Mario Sucic; Maria Medvidovic-Grubisic; Tatjana Pavelic Turudic; Igor Petrovic; Sven Seiwerth; Predrag Sikiric
Journal:  Inflammopharmacology       Date:  2017-05-17       Impact factor: 4.473

8.  Increased dopamine receptor binding in duodenal mucosa of duodenal ulcer patients.

Authors:  D E Hernandez; C H Walker; J E Valenzuela; G A Mason
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

9.  Effects of dopamine and alpha-2 adrenoreceptor blockade on L-dopa and cholecystokinin-induced gastroprotection.

Authors:  J M Cross; D W Mercer; J Gunter; T A Miller
Journal:  J Gastrointest Surg       Date:  1997 May-Jun       Impact factor: 3.452

10.  Inhibition and stimulation of prolactin release. Delayed response in duodenal ulcer patients.

Authors:  I Rotkvić; D Hrabar; H Krpan; M Banić; T Brkić; M Duvnjak; V Zjacić; P Sikirić
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.